CD21 antibody (C-Term)
Quick Overview for CD21 antibody (C-Term) (ABIN452871)
Target
See all CD21 (CR2) AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- C-Term
-
Specificity
- This antibody detects CD21 at C-term.
-
Cross-Reactivity (Details)
- Species reactivity (tested):Human
-
Purification
- Purified through a protein A column, followed by peptide affinity purification
-
Immunogen
- KLH conjugated synthetic peptide selected from the C-terminal region of human CR2
-
-
-
-
Application Notes
-
Western blot: 1: 100 - 1: 500. ELISA: 1: 1,000. Immunohistochemistry on paraffin sections: 1: 50 - 1: 100.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user. -
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 0.25 mg/mL
-
Buffer
- PBS with 0.09 % (W/V) sodium azide
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handling Advice
- Avoid repeated freezing and thawing.
-
Storage
- 4 °C/-20 °C
-
Storage Comment
- Store the antibody at 2 - 8 °C up to one month or (in aliquots) at -20 °C for longer.
-
-
- CD21 (CR2) (Complement Component (3d/Epstein Barr Virus) Receptor 2 (CR2))
-
Alternative Name
- CD21
-
Background
- CR2 is a membrane protein, which functions as a receptor for Epstein-Barr virus (EBV) binding on B and T lymphocytes.Synonyms: C3DR, C3d receptor, CR2, Complement C3d receptor, Complement receptor type 2, Dendritic Cell Marker, EBV Receptor, Epstein-Barr virus receptor
-
Molecular Weight
- 112916 Da
-
Gene ID
- 1380
-
NCBI Accession
- NP_001006659
-
UniProt
- P20023
-
Pathways
- Complement System
Target
-